{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:15:53Z","timestamp":1788966953659,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["920280"],"award-info":[{"award-number":["920280"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-5209-5","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T20:31:43Z","timestamp":1545424303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["HTLV-1-host interactions on the development of adult T cell leukemia\/lymphoma: virus and host gene expressions"],"prefix":"10.1186","volume":"18","author":[{"given":"Hanieh","family":"Tarokhian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Mosavat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Shirdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houshang","family":"Rafatpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Akbarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Bari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Abdolrahim","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,22]]},"reference":[{"issue":"7","key":"5209_CR1","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.3390\/v7072793","volume":"7","author":"A Carpentier","year":"2015","unstructured":"Carpentier A, Barez PY, Hamaidia M, Gazon H, de Brogniez A, Perike S, Gillet N, Willems L. Modes of human T cell leukemia virus type 1 transmission, replication and persistence. Viruses. 2015;7(7):3603\u201324.","journal-title":"Viruses"},{"key":"5209_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.","journal-title":"Front Microbiol"},{"issue":"3","key":"5209_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcv.2011.07.004","volume":"52","author":"H Rafatpanah","year":"2011","unstructured":"Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, Sohgandi L, Azarpazhooh MR, Rezaee SA, Farid R, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol. 2011;52(3):172\u20136.","journal-title":"J Clin Virol"},{"issue":"4","key":"5209_CR4","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s13311-015-0369-3","volume":"12","author":"R Boostani","year":"2015","unstructured":"Boostani R, Vakili R, Hosseiny SS, Shoeibi A, Fazeli B, Etemadi MM, Sabet F, Valizade N, Rezaee SA. Triple therapy with prednisolone, Pegylated interferon and sodium valproate improves clinical outcome and reduces human T-cell leukemia virus type 1 (HTLV-1) Proviral load, tax and HBZ mRNA expression in patients with HTLV-1-associated myelopathy\/tropical spastic Paraparesis. Neurotherapeutics. 2015;12(4):887\u201395.","journal-title":"Neurotherapeutics"},{"issue":"2","key":"5209_CR5","first-page":"111","volume":"25","author":"S Kamihira","year":"2003","unstructured":"Kamihira S, Dateki N, Sugahara K, Hayashi T, Harasawa H, Minami S, Hirakata Y, Yamada Y. Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count. Int J Lab Hematol. 2003;25(2):111\u20137.","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"5209_CR6","doi-asserted-by":"publisher","first-page":"e1001274","DOI":"10.1371\/journal.ppat.1001274","volume":"7","author":"Y Satou","year":"2011","unstructured":"Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, Shimizu K, Ohshima K, Green PL, Ohkura N, et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011;7(2):e1001274.","journal-title":"PLoS Pathog"},{"issue":"9","key":"5209_CR7","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1182\/blood-2010-11-321364","volume":"118","author":"G Belrose","year":"2011","unstructured":"Belrose G, Gross A, Olindo S, Lezin A, Dueymes M, Komla-Soukha I, Smadja D, Tanaka Y, Willems L, Mesnard JM, et al. Effects of valproate on tax and HBZ expression in HTLV-1 and HAM\/TSP T lymphocytes. Blood. 2011;118(9):2483\u201391.","journal-title":"Blood"},{"issue":"12","key":"5209_CR8","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1182\/blood-2008-06-161729","volume":"113","author":"T Zhao","year":"2009","unstructured":"Zhao T, Yasunaga J-i, Satou Y, Nakao M, Takahashi M, Fujii M, Matsuoka M. Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-\u03baB. Blood. 2009;113(12):2755\u201364.","journal-title":"Blood"},{"issue":"2","key":"5209_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.virol.2007.09.003","volume":"370","author":"SJ Jeong","year":"2008","unstructured":"Jeong SJ, Dasgupta A, Jung KJ, Um JH, Burke A, Park HU, Brady JN. PI3K\/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells. Virology. 2008;370(2):264\u201372.","journal-title":"Virology"},{"issue":"3","key":"5209_CR10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/sj.leu.2402824","volume":"17","author":"F Chang","year":"2003","unstructured":"Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA. Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia. 2003;17(3):590\u2013603.","journal-title":"Leukemia"},{"issue":"7","key":"5209_CR11","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1182\/blood.V93.7.2353","volume":"93","author":"L Jia","year":"1999","unstructured":"Jia L, Macey MG, Yin Y, Newland AC, Kelsey SM. Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis. Blood. 1999;93(7):2353\u20139.","journal-title":"Blood"},{"issue":"5","key":"5209_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0022-2143(03)00134-3","volume":"142","author":"K Nakashima","year":"2003","unstructured":"Nakashima K, Kawakami A, Yamasaki S, Nakamura H, Kamachi M, Miyashita T, Tanaka F, Izumi Y, Tamai M, Ida H. Protection of mitochondrial perturbation by human T-lymphotropic virus type 1 tax through induction of Bcl-xL expression. J Lab Clin Med. 2003;142(5):341\u20137.","journal-title":"J Lab Clin Med"},{"key":"5209_CR13","doi-asserted-by":"publisher","first-page":"479013","DOI":"10.1155\/2011\/479013","volume":"2011","author":"M Tagawa","year":"2011","unstructured":"Tagawa M, Kawamura K, Li Q, Tada Y, Hiroshima K, Shimada H. A possible anticancer agent, type III interferon, activates cell death pathways and produces antitumor effects. Clin Dev Immunol. 2011;2011:479013.","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"5209_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.antiviral.2012.04.011","volume":"95","author":"RR Tian","year":"2012","unstructured":"Tian RR, Guo HX, Wei JF, Yang CK, He SH, Wang JH. IFN-lambda inhibits HIV-1 integration and post-transcriptional events in vitro, but there is only limited in vivo repression of viral production. Antivir Res. 2012;95(1):57\u201365.","journal-title":"Antivir Res"},{"issue":"39","key":"5209_CR15","doi-asserted-by":"publisher","first-page":"6035","DOI":"10.1038\/sj.onc.1208970","volume":"24","author":"CR Bangham","year":"2005","unstructured":"Bangham CR, Osame M. Cellular immune response to HTLV-1. Oncogene. 2005;24(39):6035\u201346.","journal-title":"Oncogene"},{"issue":"9","key":"5209_CR16","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/v3091532","volume":"3","author":"N Araya","year":"2011","unstructured":"Araya N, Sato T, Yagishita N, Ando H, Utsunomiya A, Jacobson S, Yamano Y. Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease. Viruses. 2011;3(9):1532\u201348.","journal-title":"Viruses."},{"issue":"1","key":"5209_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1742-4690-10-91","volume":"10","author":"G Kchour","year":"2013","unstructured":"Kchour G, Rezaee SR, Farid R, Ghantous A, Rafatpanah H, Tarhini M, Kooshyar M-M, El Hajj H, Berry F, Mortada M. The combination of arsenic, interferon-alpha, and zidovudine restores an \u201cimmunocompetent-like\u201d cytokine expression profile in patients with adult T-cell leukemia lymphoma. Retrovirology. 2013;10(1):91.","journal-title":"Retrovirology"},{"issue":"6","key":"5209_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2217\/fvl.12.44","volume":"7","author":"NE Martinez","year":"2012","unstructured":"Martinez NE, Sato F, Kawai E, Omura S, Chervenak RP, Tsunoda I. Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis. Future Virol. 2012;7(6):593\u2013608.","journal-title":"Future Virol"},{"issue":"16","key":"5209_CR19","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1182\/blood-2009-07-231050","volume":"116","author":"AY Swaims","year":"2010","unstructured":"Swaims AY, Khani F, Zhang Y, Roberts AI, Devadas S, Shi Y, Rabson AB. Immune activation induces immortalization of HTLV-1 LTR-tax transgenic CD4+ T cells. Blood. 2010;116(16):2994\u20133003.","journal-title":"Blood"},{"issue":"8","key":"5209_CR20","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","volume":"116","author":"M Iwanaga","year":"2010","unstructured":"Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, Ogata M, Kikuchi H, Sagara Y, Uozumi K, et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010;116(8):1211\u20139.","journal-title":"Blood"},{"issue":"3","key":"5209_CR21","first-page":"208","volume":"16","author":"MM Akbarin","year":"2013","unstructured":"Akbarin MM, Rahimi H, Hassannia T, Shoja Razavi G, Sabet F, Shirdel A. Comparison of HTLV-I Proviral load in adult T cell leukemia\/lymphoma (ATL), HTLV-I-associated myelopathy (HAM-TSP) and healthy carriers. Iran J Basic Med Sci. 2013;16(3):208\u201312.","journal-title":"Iran J Basic Med Sci"},{"issue":"3","key":"5209_CR22","first-page":"228","volume":"7","author":"T Matsuzaki","year":"2001","unstructured":"Matsuzaki T, Nakagawa M, Nagai M, Usuku K, Higuchi I, Arimura K, Kubota H, Izumo S, Akiba S, Osame M. HTLV-I proviral load correlates with progression of motor disability in HAM\/TSP: analysis of 239 HAM\/TSP patients including 64 patients followed up for 10 years. J Neuro-Oncol. 2001;7(3):228\u201334.","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"5209_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.20144","volume":"110","author":"A Okayama","year":"2004","unstructured":"Okayama A, Stuver S, Matsuoka M, Ishizaki J, Gi T, Kubuki Y, Mueller N, Cc H, Tachibana N, Tsubouchi H. Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia\/lymphoma in asymptomatic carriers. Int J Cancer. 2004;110(4):621\u20135.","journal-title":"Int J Cancer"},{"issue":"9","key":"5209_CR24","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.3390\/v2092037","volume":"2","author":"P Kannian","year":"2010","unstructured":"Kannian P, Green PL. Human T Lymphotropic virus type 1 (HTLV-1): molecular biology and oncogenesis. Viruses. 2010;2(9):2037\u201377.","journal-title":"Viruses."},{"issue":"9","key":"5209_CR25","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1182\/blood-2008-04-154286","volume":"112","author":"J Arnold","year":"2008","unstructured":"Arnold J, Zimmerman B, Li M, Lairmore MD, Green PL. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood. 2008;112(9):3788\u201397.","journal-title":"Blood"},{"issue":"1","key":"5209_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1742-4690-6-71","volume":"6","author":"M Matsuoka","year":"2009","unstructured":"Matsuoka M, Green PL. The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology. 2009;6(1):71.","journal-title":"Retrovirology"},{"issue":"1","key":"5209_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-4690-6-19","volume":"6","author":"M Saito","year":"2009","unstructured":"Saito M, Matsuzaki T, Satou Y, Yasunaga J-i, Saito K, Arimura K, Matsuoka M, Ohara Y. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Retrovirology. 2009;6(1):19.","journal-title":"Retrovirology"},{"key":"5209_CR28","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1038\/ncomms4393","volume":"5","author":"S Nakahata","year":"2014","unstructured":"Nakahata S, Ichikawa T, Maneesaay P, Saito Y, Nagai K, Tamura T, Manachai N, Yamakawa N, Hamasaki M, Kitabayashi I, et al. Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers. Nat Commun. 2014;5:3393.","journal-title":"Nat Commun"},{"issue":"2","key":"5209_CR29","first-page":"182","volume":"47","author":"T Nakamura","year":"2009","unstructured":"Nakamura T. HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy. Folia Neuropathol. 2009;47(2):182\u201394.","journal-title":"Folia Neuropathol"},{"issue":"1","key":"5209_CR30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V96.1.275","volume":"96","author":"C Nicot","year":"2000","unstructured":"Nicot C, Mahieux R, Takemoto S, Franchini G. Bcl-XL is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples. Blood. 2000;96(1):275\u201381.","journal-title":"Blood"},{"issue":"1","key":"5209_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/NEN.0000000000000141","volume":"74","author":"E Matsuura","year":"2015","unstructured":"Matsuura E, Kubota R, Tanaka Y, Takashima H, Izumo S. Visualization of HTLV-1\u2013specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1\u2013associated myelopathy\/tropical spastic Paraparesis. J Neuropathol Exp Neurol. 2015;74(1):2\u201314.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"5209_CR32","first-page":"359","volume":"8","author":"M Osame","year":"2002","unstructured":"Osame M. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM\/TSP). J Neuro-Oncol. 2002;8(5):359\u201364.","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"5209_CR33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V61.1.192.192","volume":"61","author":"Y Yamada","year":"1983","unstructured":"Yamada Y. Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia\/lymphoma. Blood. 1983;61(1):192\u20139.","journal-title":"Blood"},{"issue":"8","key":"5209_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1349-7006.2005.00080.x","volume":"96","author":"T Kohno","year":"2005","unstructured":"Kohno T, Yamada Y, Akamatsu N, Kamihira S, Imaizumi Y, Tomonaga M, Matsuyama T. Possible origin of adult T-cell leukemia\/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells. Cancer Sci. 2005;96(8):527\u201333.","journal-title":"Cancer Sci"},{"issue":"2","key":"5209_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/intimm\/dxh366","volume":"18","author":"S Chen","year":"2006","unstructured":"Chen S, Ishii N, Ine S, Ikeda S, Fujimura T, Ndhlovu LC, Soroosh P, Tada K, Harigae H, Kameoka J, et al. Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. Int Immunol. 2006;18(2):269\u201377.","journal-title":"Int Immunol"},{"issue":"5","key":"5209_CR36","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1172\/JCI23913","volume":"115","author":"Y Yamano","year":"2005","unstructured":"Yamano Y, Takenouchi N, Li H-C, Tomaru U, Yao K, Grant CW, Maric DA, Jacobson S. Virus-induced dysfunction of CD4+ CD25+ T cells in patients with HTLV-I\u2013associated neuroimmunological disease. J Clin Invest. 2005;115(5):1361\u20138.","journal-title":"J Clin Invest"},{"issue":"11","key":"5209_CR37","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1086\/503874","volume":"193","author":"U Oh","year":"2006","unstructured":"Oh U, Grant C, Griffith C, Fugo K, Takenouchi N, Jacobson S. Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 infection. J Infect Dis. 2006;193(11):1557\u201366.","journal-title":"J Infect Dis"},{"issue":"5609","key":"5209_CR38","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057\u201361.","journal-title":"Science"},{"key":"5209_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fmicb.2012.00247","volume":"3","author":"T Zhao","year":"2012","unstructured":"Zhao T, Matsuoka M. HBZ and its roles in HTLV-1 oncogenesis. Front Microbiol. 2012;3:247.","journal-title":"Front Microbiol"},{"key":"5209_CR40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol. 2009;27:485\u2013517.","journal-title":"Annu Rev Immunol"},{"issue":"7262","key":"5209_CR41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature08309","volume":"461","author":"D Ge","year":"2009","unstructured":"Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461(7262):399\u2013401.","journal-title":"Nature"},{"issue":"7265","key":"5209_CR42","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461(7265):798\u2013801.","journal-title":"Nature"},{"issue":"1","key":"5209_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ni875","volume":"4","author":"SV Kotenko","year":"2003","unstructured":"Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. IFN-\u03bbs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 2003;4(1):69.","journal-title":"Nat Immunol"},{"issue":"5","key":"5209_CR44","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1002\/jcb.26546","volume":"119","author":"SH Mozhgani","year":"2018","unstructured":"Mozhgani SH, Zarei-Ghobadi M, Teymoori-Rad M, Mokhtari-Azad T, Mirzaie M, Sheikhi M, Jazayeri SM, Shahbahrami R, Ghourchian H, Jafari M, et al. Human T-lymphotropic virus 1 (HTLV-1) pathogenesis: a systems virology study. J Cell Biochem. 2018;119(5):3968\u201379.","journal-title":"J Cell Biochem"},{"issue":"4","key":"5209_CR45","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00430-017-0506-1","volume":"206","author":"S Ramezani","year":"2017","unstructured":"Ramezani S, Shirdel A, Rafatpanah H, Akbarin MM, Tarokhian H, Rahimi H, Bari A, Jahantigh HR, Rezaee SA. Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia\/lymphoma. Med Microbiol Immunol. 2017;206(4):327\u201335.","journal-title":"Med Microbiol Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5209-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-5209-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5209-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T19:09:06Z","timestamp":1576955346000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-5209-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5209"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-5209-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"25 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed, approved and supervised by Mashhad University of Medical Sciences Biomedical Ethics Committee (IR.MUMS.REC.920280). The written informed consents were obtained from all the patients and control subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1287"}}